All In Biotech

Free tool

FAERS Monitor: Pokonza

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 208019 or its brand name (Pokonza, Potassium Chloride). Reports on generic versions are filed under their own applications.

Reports

93,855

Serious

69,878

74% of reports

Hospitalization

43,163

Death reported

13,688

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • diarrhoea6,883
  • dyspnoea6,840
  • nausea6,627
  • fatigue6,413
  • death4,665
  • pneumonia4,544
  • headache4,281
  • vomiting4,216
  • asthenia4,206
  • off label use4,119
  • dizziness4,051
  • pain3,918
  • fall3,687
  • drug ineffective3,641
  • anaemia3,172

Reports by year received

View as table
YearReports
2004901
20051,824
20061,348
20071,683
20082,435
20092,665
20102,185
20112,587
20123,568
20132,074
20142,486
20153,933
20164,707
20174,800
20185,794
20195,661
20205,671
20216,017
20226,667
20236,693
20247,494
20257,576
20265,080

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,960,304 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
anaemiaSignal3,1723.83.66,413
pneumoniaSignal4,5443.23.16,781
dyspnoeaSignal6,8402.72.77,603
astheniaSignal4,2062.52.43,895
fallSignal3,6872.52.43,330
diarrhoeaSignal6,8832.42.45,762
vomitingSignal4,2162.02.02,196
nausea6,6271.91.82,831
fatigue6,4131.91.82,592
dizziness4,0511.81.81,539
headache4,2811.51.5814
pain3,9181.41.4522
death4,6651.21.2183
off label use4,1191.11.012
drug ineffective3,6410.60.6914

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.